Anna Wonnerth
Impact in
-
- Atherosclerosis and Cardiovascular Diseases
- IL-33, ST2, and ILC Pathways
-
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 3
- COVID-19 and healthcare impacts 1
-
- Atherosclerosis and Cardiovascular Diseases 3
- Co-authors
- Johann Wojta (10 shared papers)Kurt Huber (8 shared papers)Katharina M. Katsaros (7 shared papers)Walter Stefan Speidl (8 shared papers)Konstantin Alexander Krychtiuk (7 shared papers)Thomas Werner Weiss (3 shared papers)Serdar Farhan (3 shared papers)Ioannis Tentzeris (3 shared papers)
In The Last Decade
Anna Wonnerth
12 papers receiving 497 citations
Peers
Comparison fields: 5 of 59
- Immunology 126
- Surgery 147
- Cardiology and Cardiovascular Medicine 69
- Endocrinology, Diabetes and Metabolism 44
- Clinical Biochemistry 10
Countries citing papers authored by Anna Wonnerth
This map shows the geographic impact of Anna Wonnerth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wonnerth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wonnerth more than expected).
Fields of papers citing papers by Anna Wonnerth
This network shows the impact of papers produced by Anna Wonnerth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wonnerth. The network helps show where Anna Wonnerth may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Wonnerth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 234 | |
| 2 | 2014 | 77 | |
| 3 | 2015 | 42 | |
| 4 | 2014 | 39 | |
| 5 | 2014 | 36 | |
| 6 | 2015 | 35 | |
| 7 | 2015 | 14 | |
| 8 | 2014 | 10 | |
| 9 | 2015 | 9 | |
| 10 | 2011 | 8 | |
| 11 | 2012 | 3 | |
| 12 | 2022 | 1 |
About Anna Wonnerth
Anna Wonnerth is a scholar working on Oncology, Immunology, Surgery, Pulmonary and Respiratory Medicine and Hematology, having authored 12 papers that have together received 508 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Coronary Interventions and Diagnostics (2 papers), Erythropoietin and Anemia Treatment (1 paper), COVID-19 and healthcare impacts (1 paper) and Acute Ischemic Stroke Management (1 paper). The work is most often cited by research in Immunology (126 citations), Surgery (147 citations), Cardiology and Cardiovascular Medicine (69 citations), Endocrinology, Diabetes and Metabolism (44 citations) and Clinical Biochemistry (10 citations). Anna Wonnerth has collaborated with scholars based in Austria, Slovakia and Norway. Frequent co-authors include Johann Wojta, Kurt Huber, Katharina M. Katsaros, Walter Stefan Speidl, Konstantin Alexander Krychtiuk, Thomas Werner Weiss, Serdar Farhan, Ioannis Tentzeris, Rudolf Járai and Svitlana Demyanets. Their work appears in journals such as PLoS ONE, Stroke, The American Journal of Cardiology, British Journal of Pharmacology and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.